Protective effect of allopurinol on experimental ovarian ischemia-reperfusion injury model of rats

Basit Öğe Kaydı
dc.contributor.authorYurtçu E.
dc.contributor.authorTogrul C.
dc.contributor.authorDeveci E.
dc.date.accessioned2024-04-24T18:46:16Z
dc.date.available2024-04-24T18:46:16Z
dc.date.issued2020
dc.departmentDicle Üniversitesien_US
dc.description.abstractOBJECTIVE: To investigate the effect of allopurinol on an experimentally induced ovarian ischemia-reperfusion model. STUDY DESIGN: Female rats in the estrous cycle (n=32) were divided into sham, ischemia, ischemia-reperfusion, and ischemia-reperfusion+allopurinol-treated groups. In the sham group the ovaries were opened and closed. In the ischemia group the ovaries were sealed for 2-hour ischemia. In the ischemia-reperfusion group, after ischemia, 2.5 hours of reperfusion was done. In the ischemia-reperfusion+allopurinol group, 3 hours after ischemia-reperfusion, 50 mg/kg allopurinol was administered. RESULTS: In the allopurinol-administered group, MDA levels were decreased. GSH values were decreased in the ischemia and ischemia-reperfusion group but increased in the allopurinol-treated group as compared to the control group. Caspase-3 expression was positive in enlarged corpus luteum cells. sFlt-1 expression was positive in vascular endothelial cells between preantral and antral follicles and some macrophages but negative in granular cells. In the ischemia group, sFlt-1 expression was positive in degenerative preantral and antral follicle cells, endothelial cells, and intense inflammatory cells. In the ischemia-reperfusion group, increased sFlt-1 expression was observed in luteal cells of the corpus luteum, vascular endothelial, and inflammatory cells. In the ischemia-reperfusion+allopurinol group, granular cells and corpus luteum cells showed decreased sFlt-1 expression, while being positive in vascular endothelial cells. CONCLUSION: Allopurinol inhibits development of apoptosis and reduces oxidative load in the ischemia-reperfusion stage, thus protecting the ovary from damage. © Science Printers and Publishers, Inc.en_US
dc.identifier.endpage16en_US
dc.identifier.issn2578-742X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85089374672
dc.identifier.scopusqualityQ4
dc.identifier.startpage8en_US
dc.identifier.urihttps://hdl.handle.net/11468/25136
dc.identifier.volume42en_US
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherScience Printers and Publishers Inc.en_US
dc.relation.ispartofAnalytical and Quantitative Cytopathology and Histopathology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAllopurinolen_US
dc.subjectCaspase-3en_US
dc.subjectFlt1 Proteinen_US
dc.subjectFms-Like Tyrosine Kinase-1en_US
dc.subjectIschemiaen_US
dc.subjectIschemia-Reperfusion İnjuryen_US
dc.subjectOvarian Diseasesen_US
dc.subjectOvarian İschemiaen_US
dc.subjectOvarian Torsionen_US
dc.subjectOvaryen_US
dc.subjectOxidative Stressen_US
dc.subjectRatsen_US
dc.subjectReperfusion İnjuryen_US
dc.subjectSflt-1en_US
dc.subjectVascular Endothelial Growth Factor Receptor-1en_US
dc.titleProtective effect of allopurinol on experimental ovarian ischemia-reperfusion injury model of ratsen_US
dc.titleProtective effect of allopurinol on experimental ovarian ischemia-reperfusion injury model of rats
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu